Skip to main content

Ardea Biosciences, Inc. (NASDAQ:RDEA) Investor Investigation Over Potential Breaches Of Fiduciary Duties In Connection With The Proposed Merger with AstraZeneca

  • If you who purchased shares of Ardea Biosciences, Inc. (NASDAQ:RDEA) prior to April 23, 2012 and currently hold any of those NASDAQ:RDEA shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

April 23, 2012 (Shareholders Foundation) -- An investigation on behalf of investors in NASDAQ:RDEA shares concerning whether the offer by AstraZeneca to merger with Ardea Biosciences, $32.00 per share and the takeover process are unfair to investors in Ardea Biosciences, Inc. (NASDAQ:RDEA) was announced. The investigations by law firms concern whether certain officers and dire...

You must register (for free) or login to view the entire investigation.